Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegylated Interferon and Ribavirin in Post-Transplant HCV
NCT00383864Phase 4Completed
- Sponsor
- Hospital Clínic de Barcelona
- Start
- Jul 2001
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised trial of pegylated interferon alpha and ribavirin in hepatitis C (HCV) (2 arms), sponsored by Hospital Clínic de Barcelona. Primary endpoint: Histological improvement (decrease in at least one fibrosis stage). Started Jul 2001; status: completed.
02
Drugs
pegylated interferon alpharibavirin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00383864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00383864.